Physician profile
Herman Levy
NPI 1184610313
$5,297.78
in general payments reported to CMS, 2019-2025
37 companies · $1,129 in 2025
The $1,129 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,119 · 2020: $496 · 2021: $413 · 2022: $765 · 2023: $628 · 2024: $746 · 2025: $1,129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,364 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,363.65 |
| Education | $139.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,184.95 | 2019-2025 | Nucala, Trelegy Ellipta |
| Grifols USA, LLC | $505.61 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Regeneron Healthcare Solutions, INC. | $467.69 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $411.97 | 2019-2025 | Ofev |
| Astrazeneca Pharmaceuticals Lp | $402.37 | 2020-2025 | Airsupra, Fasenra, Breztri |
| Genzyme Corporation | $304.28 | 2019-2025 | |
| Amgen INC. | $257.91 | 2021-2025 | Tezspire |
| Sunovion Pharmaceuticals INC. | $186.34 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $161.35 | 2025 | Lumryz |
| Abbvie INC. | $144.98 | 2021-2025 | |
| Mallinckrodt Hospital Products INC. | $135.16 | 2022-2025 | Acthar |
| Inspire Medical Systems, INC. | $131.14 | 2023 | Inspire |
| Mylan Specialty L.P. | $106.01 | 2019 | |
| Pfizer INC. | $85.21 | 2022-2024 | |
| Philips North America LLC | $74.55 | 2019-2024 | (Ak6) Vest Therapy |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $74.46 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $67.07 | 2019-2022 | |
| Baxter Healthcare | $64.22 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $57.51 | 2019-2025 | |
| Inogen, INC. | $52.28 | 2022-2024 | Inogen |
| Bard Peripheral Vascular, INC. | $47.66 | 2024 | Venclose Maven Catheter |
| United Therapeutics Corporation | $45.77 | 2021-2023 | Tyvaso |
| Verona Pharma, INC. | $42.11 | 2025 | Ohtuvayre |
| Ani Pharmaceuticals, INC. | $39.17 | 2024-2025 | Purified Cortrophin Gel |
| Pulmonx Corporation | $38.35 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Liquidia Technologies, INC. | $26.63 | 2025 | Yutrepia |
| Merck Sharp & Dohme LLC | $22.71 | 2025 | Winrevair |
| Idorsia Pharmaceuticals US INC | $21.70 | 2023 | Quviviq |
| Boston Scientific Corporation | $20.41 | 2021 | |
| Circassia INC. | $18.99 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $18.80 | 2020 | |
| Electromed, INC. | $18.27 | 2024 | Smartvest |
| Paratek Pharmaceuticals, INC. | $14.35 | 2024 | Nuzyra |
| Allergan, INC. | $12.84 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $12.27 | 2020 | |
| Fisher & Paykel Healthcare INC | $11.67 | 2021 | |
| Genentech USA, INC. | $11.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Levy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.